Correlation Between AN2 Therapeutics and INmune Bio
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and INmune Bio, you can compare the effects of market volatilities on AN2 Therapeutics and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and INmune Bio.
Diversification Opportunities for AN2 Therapeutics and INmune Bio
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AN2 and INmune is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and INmune Bio go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and INmune Bio
Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the INmune Bio. But the stock apears to be less risky and, when comparing its historical volatility, AN2 Therapeutics is 4.13 times less risky than INmune Bio. The stock trades about -0.56 of its potential returns per unit of risk. The INmune Bio is currently generating about 0.39 of returns per unit of risk over similar time horizon. If you would invest 530.00 in INmune Bio on November 4, 2024 and sell it today you would earn a total of 392.00 from holding INmune Bio or generate 73.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. INmune Bio
Performance |
| Timeline |
| AN2 Therapeutics |
| INmune Bio |
AN2 Therapeutics and INmune Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and INmune Bio
The main advantage of trading using opposite AN2 Therapeutics and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma | INmune Bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |